โšกYour ready-to-use recruitment solution: IRB-compliant, SEO-optimized website that automatically routes qualified patient leads to your clinical study (14-day free trial, then $44/mo)

NCT06555328RECRUITINGIRB Ready

Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa

Sponsored by InflaRx GmbH

Quick Self-Assessment

See if you qualify and express your interest

Preparing your pre-screening questions...
๐Ÿ“Š
1 of 75 participants interested
1% interest

Express Your Interest Today

Interested in learning more? Complete the form below.

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Advance Medical Science

    Contribute to groundbreaking research

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel (varies by study)

  • Help Others

    Benefit future patients

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3In-person assessment if eligible
  4. 4Begin participation

About This Study

The study duration for an individual subject includes screening (14 days), the treatment period (28 days) and the observational follow-up period of 28 days, in total 70 days ยฑ 6 days. All subjects will receive IMP for 28 days followed by one End of Study (EOS) visit, 4 weeks after EOT visit.

Who Can Participate

Inclusion Criteria

Signed informed consent.
Subjects must be 18 years or older at the time of signing the informed consent.

Exclusion Criteria

Subjects with known severe or life-threatening hypersensitivity reaction to any other CSU/HS treatment according to National Cancer Institute-Common Terminology Criteria for Adverse Events (NCI-CTCAE).
Subjects who have any other skin disease that may interfere with assessment of CSU or HS.
Subjects who have an active infection or history of infection(s) as follows: 1. Any infection requiring systemic treatment within 14 days prior to baseline. 2. A history of opportunistic, recurrent, or chronic infections that, in the opinion of the Investigator, might cause this study to be detrimental to the subject.
Subjects with known progressed liver disease (Child-Pugh B or C)

โ“ Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility during the screening process.

Study Details

๐Ÿ“‹

Study Type

INTERVENTIONAL

๐Ÿ‘ฅ

Target Enrollment

75 participants

๐ŸŽ‚

Age Range

18 Years - 99 Years

โšง

Gender

ALL

๐Ÿข

Sponsor

InflaRx GmbH

Study Locations

Choose your preferred location or select flexible during enrollment

RECRUITING

Fountain Valley

California

Location available
View Fountain Valley location page
RECRUITING

North Miami Beach

Florida

Location available
View North Miami Beach location page
RECRUITING

Tampa

Florida

Location available
View Tampa location page
RECRUITING

Indianapolis

Indiana

Location available
View Indianapolis location page
RECRUITING

Murray

Kentucky

Location available
View Murray location page
RECRUITING

Saint Joseph

Missouri

Location available
View Saint Joseph location page
RECRUITING

Kew Gardens

New York

Location available
View Kew Gardens location page
RECRUITING

Fairborn

Ohio

Location available
View Fairborn location page
RECRUITING

Texas City

Texas

Location available
View Texas City location page

Frequently Asked Questions

Q:What is a clinical trial?

A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.

Q:Will I be compensated?

Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.

Q:Will I receive a placebo instead of treatment?

When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.

Q:Can I leave a trial if I change my mind?

Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.

Q:How long does a clinical trial last?

Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.

Still have questions? Our study coordinators are here to help.

Ready to Make a Difference?

Express your interest in this groundbreaking clinical trial

๐Ÿ”’ Secure ยท ๐Ÿฅ Expert Care

Looking for Chronic Spontaneous Urticaria Treatment in Fountain Valley?

Join others in California exploring innovative treatment options through clinical research

Chronic Spontaneous Urticaria Treatment Options in Fountain Valley, California

If you're searching for Chronic Spontaneous Urticaria treatment in Fountain Valley, participating in a clinical research study may provide access to innovative approaches under expert medical supervision. This study is actively recruiting participants in Fountain Valley, North Miami Beach, Tampa and surrounding areas.

Clinical trials offer participants the opportunity to receive cutting-edge treatments while contributing to medical research that may help future patients with Chronic Spontaneous Urticaria. All study-related care is provided at no cost to participants.

Local Sites
3 locations in California
Now Enrolling
Up to 75 participants
Quick Start
Screening available now

Why Consider a Clinical Trial for Chronic Spontaneous Urticaria?

Potential Benefits

  • โœ“Access to new treatment approaches before public availability
  • โœ“Close monitoring by experienced medical professionals
  • โœ“Study-related care provided at no cost
  • โœ“Contribute to medical research for Chronic Spontaneous Urticaria

What to Expect

  • โ†’Initial screening to determine eligibility
  • โ†’Regular check-ups and monitoring visits
  • โ†’Possible compensation for time and travel
  • โ†’You can withdraw at any time

Frequently Asked Questions About This Chronic Spontaneous Urticaria Study

Important Clinical Trial Information

This information is provided for educational purposes and does not constitute medical advice. Clinical trial participation involves potential risks and benefits. Eligibility requirements apply and will be assessed during the screening process.

Study identifier: NCT06555328. For complete study details, visit ClinicalTrials.gov. Always consult with your healthcare provider before making decisions about your medical care or participating in clinical research.